Literature DB >> 15845622

Altered levels of angiopoietin 1 and tie 2 are associated with androgen-regulated vascular regression and growth in the ventral prostate in adult mice and rats.

Anna Johansson1, Stina Häggström Rudolfsson, Pernilla Wikström, Anders Bergh.   

Abstract

The involution of the rat ventral prostate gland after castration could be caused by primary changes in the vasculature. To explore the mechanisms, we studied the effects of castration and testosterone treatment on the vasculature in the ventral prostate in adult rats and mice. Androgen receptor expression, vascular morphology, and the expression of angiopoietin (ang) 1 and 2 and their receptor tie 2 were examined 1, 3, and 7 d after castration and after testosterone treatment of castrated animals using stereological methods, immunohistochemistry, laser capture microdissection, and Western blotting. One day after castration, the percentage of blood vessels covered with smooth muscle actin, endothelial cell proliferation, and vascular volume had decreased, whereas endothelial cell apoptosis had increased. Simultaneously, ang 1 and tie 2 protein levels decreased. Nuclear expression of androgen receptor was observed not only in glandular and stroma smooth muscle cells but also in the mural cells of prostate arteries and veins and was markedly down-regulated already 1 d after castration. Testosterone administration of castrated mice and rats reversed all the observed effects. At the mRNA level, tie 2 was exclusively, but ang 1 predominantly, expressed in the stroma, compared with the epithelial compartment. Local delivery of soluble tie 2 during testosterone-stimulated growth, inhibited vascular maturation and increased vascular volume and leukocyte infiltration compared with controls. We conclude that androgens may regulate the prostate vasculature by direct effects on mural vascular cells and by influencing the secretion of the angiopoietins, in above all, the stroma cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845622     DOI: 10.1210/en.2004-1480

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.

Authors:  Gui-Min Wang; Bruce Kovalenko; Yili Huang; David Moscatelli
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

2.  Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.

Authors:  Kumar Nikhil; Lei Chang; Keith Viccaro; Max Jacobsen; Callista McGuire; Shakti R Satapathy; Michael Tandiary; Meaghan M Broman; Gregory Cresswell; Yizhou J He; George E Sandusky; Timothy L Ratliff; Dipanjan Chowdhury; Kavita Shah
Journal:  Cancer Lett       Date:  2019-02-01       Impact factor: 8.679

3.  Pigment epithelium-derived factor stimulates tumor macrophage recruitment and is downregulated by the prostate tumor microenvironment.

Authors:  Sofia Halin; Stina Häggström Rudolfsson; Jennifer A Doll; Susan E Crawford; Pernilla Wikström; Anders Bergh
Journal:  Neoplasia       Date:  2010-04       Impact factor: 5.715

4.  Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Authors:  Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

5.  Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model.

Authors:  Sofia Halin; Stina Häggström Rudolfsson; Nico Van Rooijen; Anders Bergh
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

Review 6.  The basic biochemistry and molecular events of hormone therapy.

Authors:  Elahe A Mostaghel; Robert B Montgomery; Daniel W Lin
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

7.  Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.

Authors:  Roberto Ronca; Roberto Tamma; Daniela Coltrini; Simona Ruggieri; Marco Presta; Domenico Ribatti
Journal:  Oncotarget       Date:  2017-08-01

8.  Role of androgens for urethral homeostasis.

Authors:  Matthias D Hofer; Allen F Morey
Journal:  Transl Androl Urol       Date:  2018-08

9.  The stroma-a key regulator in prostate function and malignancy.

Authors:  Christina Hägglöf; Anders Bergh
Journal:  Cancers (Basel)       Date:  2012-05-29       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.